
    
      Patients will come to the clinic on 8 occasions: Screening, Baseline, Day 7, Day 21, Day 35,
      Day 49, Day 63 (End of Treatment) and Day 91 (Follow-up). The primary efficacy variables will
      be IGA (Investigator Global Assessment) and SCORAD (SCORing Atopic Dermatitis) .

      The secondary efficacy variables will be IGA, SCORAD, EASI (Eczema Area and Severity Index),
      IDQOL (Infant Dermatology Quality of Life), DFI (Dermatitis Family Impact), BSA, TEWL
      (Transepidermal Water Loss) and Time to Rescue Medication.
    
  